دورية أكاديمية
SP100030 is a novel T-cell-specific transcription factor inhibitor that possesses immunosuppressive activity in vivo.
| العنوان: | SP100030 is a novel T-cell-specific transcription factor inhibitor that possesses immunosuppressive activity in vivo. |
|---|---|
| المؤلفون: | Goldman ME; Department of Pharmacology, Signal Pharmaceuticals, Inc, San Diego, California 92121, USA. mgoldman@signalpharm.com, Ransone LJ, Anderson DW, Gaarde WA, Suto MJ, Sullivan RW, Shorthouse R, Morikawa M, Morris RE |
| المصدر: | Transplantation proceedings [Transplant Proc] 1996 Dec; Vol. 28 (6), pp. 3106-9. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Science Inc Country of Publication: United States NLM ID: 0243532 Publication Model: Print Cited Medium: Print ISSN: 0041-1345 (Print) Linking ISSN: 00411345 NLM ISO Abbreviation: Transplant Proc Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: New York, N.Y. : Elsevier Science Inc. Original Publication: New York Stratton. |
| مواضيع طبية MeSH: | Lymphocyte Transfusion*, Arthritis, Experimental/*immunology , Heart Transplantation/*immunology , Immunosuppressive Agents/*pharmacology , Lymph Nodes/*immunology , Lymphocytes/*immunology, Animals ; Arthritis, Experimental/prevention & control ; Body Weight/drug effects ; Dexamethasone/pharmacology ; Female ; Hyperplasia ; Isoantigens/immunology ; Lymph Nodes/pathology ; Lymphocytes/drug effects ; Lymphocytes/radiation effects ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C3H ; Organic Chemicals ; Rats ; Rats, Inbred Lew ; Spleen ; Transplantation, Heterotopic |
| المشرفين على المادة: | 0 (Immunosuppressive Agents) 0 (Isoantigens) 0 (N-(3,5-bis(trifluoromethyl)phenyl)-2-chloro-4-(trifluoromethyl)pyrimidine-5-carboxamide) 0 (Organic Chemicals) 7S5I7G3JQL (Dexamethasone) |
| تواريخ الأحداث: | Date Created: 19961201 Date Completed: 19970121 Latest Revision: 20220726 |
| رمز التحديث: | 20240627 |
| PMID: | 8962204 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 0041-1345 |
|---|